REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has ...
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced the launch of the Seer ...
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease REDWOOD CITY, ...
Seer Inc. SEER on Thursday said its Proteograph Product Suite will serve as the mass spectrometry-based workflow to profile the plasma proteome of 10,000 participants in the PRECISE-SG100K study, a ...
In recent weeks, Asian markets have shown relative stability, with China's equities consolidating gains and Japan's stock indices experiencing mixed returns amid ongoing geopolitical tensions in the ...
REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the ...
(Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the “Board”) has thoroughly reviewed and ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
As global markets navigate geopolitical tensions and inflationary pressures, the Asian market has shown resilience, with mainland equities maintaining stability amid strong economic data. In this ...
New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting proteomic studies full-service access to the Seer Proteograph™ Product Suite and mass ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results